vaccination. Two RCTs performed in patients initiating TNFi versus placebo demonstrated similar responses to influenza vaccination in the 2 arms Rituximab For patients with RMD receiving rituximab, administering influenza vaccination on schedule is conditionally recommended rather than deferring vaccination until the next rituximab administration is due. For patients with RMD receiving rituximab, deferring non-live attenuated vaccinations, other than influenza vaccination, until the next